Correlation Between BridgeBio Pharma, and Diageo Plc

Can any of the company-specific risk be diversified away by investing in both BridgeBio Pharma, and Diageo Plc at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BridgeBio Pharma, and Diageo Plc into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between BridgeBio Pharma, and Diageo plc, you can compare the effects of market volatilities on BridgeBio Pharma, and Diageo Plc and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BridgeBio Pharma, with a short position of Diageo Plc. Check out your portfolio center. Please also check ongoing floating volatility patterns of BridgeBio Pharma, and Diageo Plc.

Diversification Opportunities for BridgeBio Pharma, and Diageo Plc

-0.74

Correlation Coefficient

BridgeBio Pharma,  Diageo Plc

Pay attention - limited upside

The 3 months correlation between BridgeBio and Diageo is -0.74. Overlapping area represents the amount of risk that can be diversified away by holding BridgeBio Pharma, and Diageo plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Diageo plc and BridgeBio Pharma, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BridgeBio Pharma, are associated (or correlated) with Diageo Plc. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Diageo plc has no effect on the direction of BridgeBio Pharma, i.e., BridgeBio Pharma, and Diageo Plc go up and down completely randomly.

Pair Corralation between BridgeBio Pharma, and Diageo Plc

Assuming the 90 days horizon BridgeBio Pharma, is expected to generate 1.73 times more return on investment than Diageo Plc. However, BridgeBio Pharma, is 1.73 times more volatile than Diageo plc. It trades about 0.19 of its potential returns per unit of risk. Diageo plc is currently generating about -0.11 per unit of risk. If you would invest  2,981  in BridgeBio Pharma, on April 12, 2025 and sell it today you would earn a total of  976.00  from holding BridgeBio Pharma, or generate 32.74% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

BridgeBio Pharma,  vs.  Diageo plc

BridgeBio Pharma,

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in BridgeBio Pharma, are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, BridgeBio Pharma, reported solid returns over the last few months and may actually be approaching a breakup point.

Diageo plc

Risk-Adjusted Performance

Very Weak

Over the last 90 days Diageo plc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest fragile performance, the Stock's forward indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Pair Trading with BridgeBio Pharma, and Diageo Plc

The main advantage of trading using opposite BridgeBio Pharma, and Diageo Plc positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BridgeBio Pharma, position performs unexpectedly, Diageo Plc can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Diageo Plc will offset losses from the drop in Diageo Plc's long position.

The idea behind BridgeBio Pharma, and Diageo plc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.